Alterity Therapeutics Lim...
3.31
0.00 (0.00%)
At close: Jan 15, 2025, 2:48 PM
3.31
0.00%
After-hours Jan 15, 2025, 02:48 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
Net Income -19.12M -13.81M -12.85M -15.31M -10.06M -12.34M -8.27M -7.54M -7.73M -5.89M -13.33M -7.79M -5.24M -6.43M -4.91M -7.52M -13.59M -11.14M -11.73M -24.91M -9.83M -4.57M -5.45M
Depreciation & Amortization 147.53K 102.26K 54.21K 75.37K 112.43K 29.70K 21.80K 21.33K 22.81K 31.59K 22.38K 23.13K 19.62K 31.58K 35.29K 34.19K 25.40K 58.57K 118.27K 1.16M 1.19M 1.18M 1.16M
Stock-Based Compensation 881.95K 966.57K 1.51M 1.88M -12.02K 89.14K 764.54K 24.46K -16.50K 468.83K 1.27M 893.48K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital 23.05K -889.52K -393.29K -624.03K -3.98M 345.14K -108.87K 89.24K 52.21K 59.22K 1.64M 49.58K 45.38K -3.33K 84.39K -23.11K -841.16K 137.12K 29.65K 72.62K n/a n/a n/a
Other Non-Cash Items -261.15K -6.33M 455.57K -2.10M -12.02K 89.14K 764.54K 24.46K -16.50K -86.32K 365.99K 197.90K 239.06K 302.89K 732.50K 517.54K 4.99M 1.75M 588.79K 12.14M 1.16M 181.70K 144.31K
Deferred Income Tax n/a 2.99M -1.06M 2.33M -250.96K -493.02K -486.42K 631.56K -934.22K -4.95M -1.27M -110.97K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital 5.75M -3.94M -447.68K -4.22M 791.13K -1.33M 956.09K 975.19K 1.26M -446.85K -2.12M -1.17M -1.87M 1.54M -569.80K -23.11K -841.16K 137.12K -638.93K 233.24K 2.16M -372.88K 377.87K
Operating Cash Flow -12.61M -20.04M -12.34M -17.33M -9.43M -13.95M -6.25M -5.87M -7.42M -10.87M -13.79M -7.95M -6.85M -4.56M -4.71M -6.99M -9.41M -9.20M -11.66M -11.37M -5.31M -3.58M -3.77M
Capital Expenditures -5.72K -7.31K -89.15K -10.47K -16.74K -7.02K -62.41K -27.92K -2.31K -28.76K -23.05K -22.00K -26.76K -13.69K -22.67K -36.19K -46.71K -4.56K -55.66K -50.26K -133.55K -87.67K -84.28K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a -154.08K n/a -6.15K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a 43.99K n/a 1.47K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -29.15K n/a n/a n/a n/a 43.99K n/a 1.47K -154.08K n/a -6.15K n/a -2.67K n/a n/a -35.24K 299.47 374.64 n/a n/a n/a n/a
Investing Cash Flow -5.72K -36.46K -89.15K -10.47K -16.74K -7.02K -18.42K -27.92K -833 -182.83K -23.05K -28.15K -26.76K -16.36K -22.67K -36.19K -81.95K -4.26K -55.28K -50.26K -133.55K -87.67K -84.28K
Debt Repayment -10.37K n/a -34.51K -58.29K -89.24K n/a n/a n/a n/a n/a -810.16K 337.00K n/a 347.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -918.02K -192.34K -836.97K -2.49M -292.77K -362.32K -107.68K -159.56K 152.60K 6.84M 35.77M 15.25M 3.62M 7.99M 5.66M 100.81K -611.07K -408.68K -2.02K -48.38K -2.82M -143.57K n/a
Financial Cash Flow 9.22M 124.34K 16.30M 36.69M 3.98M 12.72M -107.68K -159.56K 152.60K 6.84M 35.21M 15.58M 3.62M 8.34M 5.66M 100.81K 13.75M 7.37M -2.02K 4.69M 31.59M 3.56M 580.65K
Net Cash Flow -3.13M -19.03M 6.69M 18.92M -5.20M -835.65K -6.65M -6.71M -6.32M 742.56K 20.82M 7.71M -3.20M 3.61M 922.32K -6.91M 3.82M -2.60M -11.45M -8.09M 25.96M -120.87K -3.27M
Free Cash Flow -12.61M -20.04M -12.43M -17.34M -9.45M -13.96M -6.31M -5.89M -7.42M -10.90M -13.81M -7.97M -6.87M -4.57M -4.73M -7.03M -9.46M -9.20M -11.71M -11.42M -5.45M -3.67M -3.85M